IRIS - Res&Arch Institutional Research Information System - Research & Archive

MENCARELLI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.388
AS - Asia 2.382
EU - Europa 2.337
SA - Sud America 374
Continente sconosciuto - Info sul continente non disponibili 163
AF - Africa 57
OC - Oceania 2
Totale 9.703
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.211
SG - Singapore 1.197
UA - Ucraina 419
IE - Irlanda 402
CN - Cina 334
IT - Italia 317
RU - Federazione Russa 311
BR - Brasile 292
HK - Hong Kong 277
SE - Svezia 227
VN - Vietnam 206
DE - Germania 155
FR - Francia 154
FI - Finlandia 137
GB - Regno Unito 81
CA - Canada 74
TR - Turchia 69
KR - Corea 55
IN - India 52
MX - Messico 30
BD - Bangladesh 27
AR - Argentina 24
PH - Filippine 23
PL - Polonia 21
IQ - Iraq 19
RO - Romania 19
CH - Svizzera 18
CO - Colombia 18
CZ - Repubblica Ceca 18
UZ - Uzbekistan 18
ES - Italia 16
EC - Ecuador 15
JP - Giappone 15
PK - Pakistan 14
ZA - Sudafrica 14
CR - Costa Rica 13
ID - Indonesia 12
SA - Arabia Saudita 12
VE - Venezuela 10
GT - Guatemala 9
HN - Honduras 9
KE - Kenya 9
NL - Olanda 9
PR - Porto Rico 9
AT - Austria 8
BE - Belgio 8
GR - Grecia 7
JM - Giamaica 7
NI - Nicaragua 7
CL - Cile 6
CW - ???statistics.table.value.countryCode.CW??? 6
MY - Malesia 6
ET - Etiopia 5
EU - Europa 5
KG - Kirghizistan 5
LB - Libano 5
MA - Marocco 5
SV - El Salvador 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
IL - Israele 4
LY - Libia 4
PA - Panama 4
PY - Paraguay 4
JO - Giordania 3
KZ - Kazakistan 3
LT - Lituania 3
NP - Nepal 3
QA - Qatar 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CG - Congo 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
GP - Guadalupe 2
NG - Nigeria 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
TH - Thailandia 2
AU - Australia 1
BB - Barbados 1
BH - Bahrain 1
BZ - Belize 1
CY - Cipro 1
DM - Dominica 1
GA - Gabon 1
HR - Croazia 1
HU - Ungheria 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
LC - Santa Lucia 1
MD - Moldavia 1
MN - Mongolia 1
Totale 9.547
Salva come PNG Salva come JPEG
Città #
Singapore 894
San Jose 553
Chandler 481
Dublin 402
Ashburn 362
Hong Kong 277
San Mateo 224
Jacksonville 192
Wilmington 150
Dong Ket 144
Santa Clara 142
Boardman 136
Council Bluffs 125
Altamura 119
Moscow 107
Medford 100
Princeton 100
Beijing 91
Lawrence 84
Lauterbourg 79
Andover 69
Ann Arbor 66
Perugia 59
New York 51
Izmir 47
Los Angeles 44
Seoul 44
Des Moines 43
São Paulo 42
Falls Church 35
Columbus 29
Saint Petersburg 28
The Dalles 28
Helsinki 24
Dallas 23
Phoenix 23
Munich 22
North Bergen 22
Ho Chi Minh City 17
Norwalk 17
Chennai 16
Orem 16
Chicago 15
Rio de Janeiro 15
Tokyo 15
Turku 15
Piscataway 14
San Paolo di Civitate 14
Toronto 14
Stockholm 13
Tashkent 13
Timisoara 13
Warsaw 13
Mexico City 12
Brooklyn 11
Hanoi 11
Houston 11
Manchester 11
Montreal 11
Rome 11
Shanghai 11
Woodbridge 11
Denver 10
London 10
Olomouc 10
Atlanta 9
Boston 9
Ottawa 9
San José 9
Brussels 8
Frankfurt am Main 8
Johannesburg 8
Naples 8
New Delhi 8
San Francisco 8
Baghdad 7
Buffalo 7
Dearborn 7
Managua 7
Milan 7
Nairobi 7
Nuremberg 7
Ankara 6
Belo Horizonte 6
Bogotá 6
Bucharest 6
Curitiba 6
Philadelphia 6
Queens 6
Quito 6
San Juan 6
Seattle 6
Willemstad 6
Addis Ababa 5
Auburn Hills 5
Bishkek 5
Charlotte 5
Guangzhou 5
Guatemala City 5
Guayaquil 5
Totale 6.045
Salva come PNG Salva come JPEG
Nome #
Recombinant galectin-1 prevents experimental colitis in mice via T cell apoptosis. 198
Activation of the bile acid receptor GPBAR1 protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs and aspirin in mice. 159
Bile-acid-activated farnesoid X receptor regulates hydrogen sulfide production and hepatic microcirculation. 149
GITR modulates innate and adaptive mucosal immunity during the development of experimental colitis in mice 149
Bile acid-activated receptors in the treatment of dyslipidemia and related disorders. 145
Activation of the farnesoid-X receptor protects against gastrointestinal injury caused by non-steroidal anti-inflammatory drugs in mice. 143
5-Amino-2-hydroxybenzoic acid 4-(5-thioxo-5H-[1,2]dithiol-3yl)-phenyl ester (ATB-429), a hydrogen sulfide-releasing derivative of mesalamine, exerts antinociceptive effects in a model of postinflammatory hypersensitivity. 142
A nitro-arginine derivative of trimebutine (NO2-Arg-Trim) attenuates pain induced by colorectal distension in conscious rats. 141
An NO derivative of ursodeoxycholic acid protects against Fas-mediated liver injury by inhibiting caspase activity 138
An NO-derivative of acetaminophen, NCX-701, spares the liver by inhibiting Fas-dependent apoptosis 136
Activation of FXR Improves Myocardial Fatty Acid Metabolism in a Rodent Model of Liver Steatosis 136
Antiatherosclerotic effect of farnesoid X receptor. 131
4-Methylenesterols from Theonella swinhoei sponge are natural pregnane-X-receptor agonists and farnesoid-X-receptor antagonists that modulate innate immunity. 130
Efficacy of the CCR5 antagonist maraviroc in reducing early, ritonavir-induced atherogenesis and advanced plaque progression in mice. 128
a Farnesoid-X-Receptor (FXR)-Glucocorticoid Receptor (GR) Cascade Regulates Intestinal Innate Immunity in Response to FXR Activation 124
3-oxa-lipoxin A4 analog treats colitis induced by Dss by attenuating inflammation and immunity. 123
A beta-oxidation-resistant lipoxin A(4) analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction 121
Development of non-antibiotic macrolide that corrects inflammation-driven immune dysfunction in models of inflammatorybowel diseases and arthritis 117
An essential role of Farnesoid X-Receptor in regulating intestinal fibrosis in murine model of chronic colitis 117
Glucocorticoid receptor mediates the gluconeogenic activity of the farnesoid X receptor in the fasting condition 116
Inhibition of NF-κB by a PXR-dependent pathwaymediates counter-regulatory activities of rifaximin on innate immunity inintestinal epithelial cells. 115
Dissociation of intestinal and hepatic activities of FXR and LXRα supports metabolic effects of terminal ileum interposition in rodents. 115
Reciprocal regulation of the bile acid-activated receptor FXR and the interferon-gamma-STAT-1 pathway in macrophages. 114
Cyclooxygenase-2-derived lipoxin A4 increases gastric resistance to aspirin-induced damage. 114
Counter-regulatory role of bile acid activated receptors in immunity andinflammation. 112
Cardiac safety and antitumoral activity of a new nitric oxide derivative of pegylated epirubicin in mice. 110
Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. 106
The HIV Matrix Protein p17 subverts Nuclear Receptors Expression and induces a STAT1-Dependent Proinflammatory Phenotype in Monocytes 106
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertension 106
The nuclear receptor FXR regulates hepatic transport and metabolism of glutamine and glutamate 105
The plant sterol guggulsterone attenuates inflammation and immune dysfunction in murine models of inflammatory bowel disease. 103
Proteinase activated receptor (PAR)-2 protects against colitis in mice. Evidence for direct modulation of lamina propria T lymphocytes. 103
Probiotics modulate intestinal expression of nuclear receptor and provide counter-regulatory signals to inflammation-driven adipose tissue activation. 102
Nitric oxide protects againist HIV gp 120 endothelial injury. 102
A Novel Source of Intestinal Damage: The HIV Protease Inhibitor Ritonavir Worsens Damage Caused by COX Inhibitors 102
Discovery that theonellasterol a marine sponge sterol is a highly selective FXR antagonist that protects against liver injury in cholestasis. 102
Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. 101
Evidence that hydrogen sulfide exerts antinociceptive effects in the gastrointestinal tract by activating KATP channels. 100
Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation 100
The bile acid receptor GPBAR-1 (TGR5) modulates integrity of intestinal barrier and immune response to experimental colitis. 100
The bile acid sensor FXR protects against dyslipidemia and aortic plaques development induced by the HIV protease inhibitor ritonavir in mice. 99
Mechanisms to prevent the toxicity of chronic neuroinflammation on forebrain cholinergic neurons 99
The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis. 98
Farnesoid-X-receptor (FXR) ligands induce a small heterodimer partner (SHP)-dependent upregulation of PPAR-gamma in hepatic stellate cells and in rat model of liver fibrosis. 98
Farnesoid X receptor suppresses constitutive androstane receptoractivity at the multidrug resistance protein-4 promoter. 96
CCR5 Antagonism by Maraviroc Reduces the Potential for Gastric Cancer Cell Dissemination. 96
FXR mediates a chromatin looping in the GR promoter thus promoting the resolution of colitis in rodents. 96
Role of the FXR in Regulating Bile Acid Homeostasis and Relevance for Human Diseases 95
Gene Expression Changes Induced by HIPEC in a Murine Model of Gastric Cancer 95
FXR an emerging therapeutic target for the treatment of atherosclerosis. 94
A hydrogen-sulfide releasing derivative of mesalamine exhibits markedly enhanced anti-inflammatory effects in experimental colitis 94
Farnesoid X receptor agonist for the treatment of liver and metabolic disorders: focus on 6-ethyl-CDCA 91
Protective effects of granulocyte macrophage colony stimulating factor (gm-Csf) in Hapten-induced colitis 90
Targetting farnesoid-X-receptor: from medicinal chemistry to disease treatment. 89
Critical role of toll-like receptors in modulating GM-CSF activity in rodent models of colitis 89
Epigenetic modulation by methionine deficiency attenuates the potential for gastric cancer cell dissemination. 89
NCX-1000, an NO derivative of UDCA, releases NO and protects against portal hypertension by inhibiting hepatic stellate cell contraction. 88
COX-2 selective inhibitors cause gastric damage in aspirin treated rats. Protective effect of nitroaspirin (NCX-4016). 87
Instruction of Intestinal Microbiota by VSL#3 Reverses NASH and Accelerated Atherosclerosis Caused by Intestinal Inflammation in ApoE(-/-) Mice 87
Impaired calcineurin signaling in myeloid cells results in downregulation of pentraxin-3 and increased susceptibility to aspergillosis 87
IL-1 beta converting enzyme is a target for nitric oxide-releasing aspirin: new insights in the antiinflammatory mechanism of nitric oxide-releasing nonsteroidal antiinflammatory drugs. 86
Proteinase activated receptor (PAR)-2 agonistic peptide protects from Th-1 mediated liver injury in mice. 86
VLA-1 immunoneutralization protects against colon damage in a mouse model of colitis 86
Nitric oxide modulates proapoptotic and antiapoptotic properties of chemotherapy agents: the case of NO-pegylated epirubicin. 85
SHP-dependent and -independent induction of peroxisomeproliferator-activated receptor-γ by the bile acid sensor farnesoid X receptorcounter-regulates the pro-inflammatory phenotype of liver myofibroblasts. 85
NCX-999, a NO-releasing derivative of UDCA, modulates hepatic stellate cells and reduces vasomotor response to nor-epinefrine in intact rats 84
In vivo administration of ritonavir worsens intestinal damage caused by cyclooxygease inhibitors. 84
The methionine connection: homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats. 83
Inhibition of hydrogen sulfide generation contributes to gastric injury caused byanti-inflammatory nonsteroidal drugs. 83
Hydrogen sulphide induces micro opioid receptor-dependent analgesia in a rodent model of visceral pain. 81
The nuclear receptor SHP (small heterodimer partner) mediates inhibitory effects of farnesoid-X-receptor (FXR) on hepatic stellate cells and protects against liver fibrosis in rodents. 81
Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. 80
Total synthesis and pharmacological characterization of solomonsterol A, a potent marine pregnane-X-receptor agonist endowed with anti-inflammatory activity. 79
The third gas: H2S regulates perfusion pressure in both theisolated and perfused normal rat liver and in cirrhosis. 79
Gastrointestinal safety and anti-inflammatory activity of HCT-1026, NO-releasing flurbiprofen, in healthy humans volunteers 79
Solomonsterol A, a marine pregnane-X-receptor agonist, attenuates inflammation and immune dysfunction in a mouse model of arthritis. 79
‘The Farnesoid X Receptor Promotes Adipocyte Differentiationd regulates adipose cell function in vivo’ 78
Different sensitivity of lamina propria T-cell subsets to nitric oxide-induced apoptosis explains immunomodulatory activity of a nitric oxidereleasing derivative of mesalamine in rodent colitis. 78
The Nuclear Receptor SHP Mediates Inhibition of Hepatic Stellate Cells by FXR and Protects Against Liver Fibrosis 78
The bile acid receptor FXR is a modulator of intestinal innate immunity. 78
H2S Induces Analgesia Is Mediated In Vivo Activation of mu Opioid Receptor and PI3K/AKT Pathway Activation 77
Role of Maraviroc in a dyslipidemic murine model of atherosclerosis RTV-induced 77
FXR Activation Reverses Insulin Resistance and Protects Against NASH Development 75
Heat shock proteins as key biological targets of the marine natural cyclopeptide perthamide 73
Co-administration of nitric oxide-aspirin (NCX-4016) andaspirin prevents platelet and monocyte activation and protects against gastric damage induced by aspirin in humans. 71
VSL#3 Resets Insulin Signaling and Protects against NASH and Atherosclerosis in a Model of Genetic Dyslipidemia and Intestinal Inflammation. 71
Celecoxib exacerbates gastrointestinal damage induced by aspirin but not by NO-aspirin (NCX-4016): A randomised, parallel group, blind-observer endoscopic study. Evidence for a protective role of NO in the gastrointestinal mucosa 71
The CCR5 Antagonist Maraviroc Reduces the Potential for Gastric Cancer Dissemination in Rodent Models of Peritoneal Metastasis 71
Plakilactones from the Marine Sponge Plakinastrella mamillaris. Discovery of a New Class of Marine Ligands of Peroxisome Proliferator-Activated Receptor gamma 70
The Farnesoid X Receptor Promotes Adipocyte Differentiation and Regulates Adipose Cell Function in Vivo 69
The bile acid sensor FXR is required for immune-regulatory activities of TLR-9 in intestinal inflammation 69
Molecular Determinants of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in a Model of Peritoneal Gastric Cancer Carcinogenesis 68
The bile acid sensor FXR regulates insulin transcription and secretion. 68
Enhanced anti-inflammatory activity of hydrogen sulfide releasing derivative of mesalamine in rodent models of colitis, involves direct inhibition of Nf-kappa B 67
The Bile Acid Receptor TGR5 Maintains Gastrointestinal Homeostasis and Its Activation Rescues From Gastrointestinal Injury Caused by ASA and NSAIDs 66
Essential Role of DNAX Adaptor Protein 12 (DAP12) and Spleen Tyrosine Kinase (Syk) in Inflammation-Driven Immune Dysfunction in Rodent Model of Colitis 65
Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. 61
Inhibition of NF-kB by a PXR-Dependent Pathway Mediates Counter-regulatory Activities of Rifaximin on Innate Immunity in Intestinal Epithelial Cells 57
FXR Activation Corrects Immune-Dysfunction and Attenuates Inflammation in a Rodent Model of Hepatitis 54
Modification of Intestinal Microbiota by VSL#3 Protects Against Development of Pain in the Neonatal Maternal Separation Model. a Whole Genome Array Investigation 53
Totale 9.703
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.900
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.900
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022701 0 0 0 32 32 120 5 274 4 8 75 151
2022/20231.563 116 295 8 154 114 173 1 84 556 0 50 12
2023/2024509 35 67 36 4 4 4 109 36 32 17 104 61
2024/20251.327 10 117 53 46 212 49 28 88 252 76 221 175
2025/20262.893 190 144 176 264 351 256 557 163 426 262 65 39
2026/2027900 51 85 213 551 0 0 0 0 0 0 0 0
Totale 9.703